Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |
mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |